TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05075005

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Treatment Cohort
Description: Subjects will walk on a specified University of Florida Natural Area Teaching Laboratory's (NATL) nature trail for approximately 30 minutes, three times per week for 8 weeks while wearing the minimalist shoes provided by the study team. Time, distance, and GPS walking route will be recorded utilizing the MapMyRun smartphone application, which is free to download and easy to use. The study team will assist each subject with downloading the application onto their smartphone and provide a brief training on app use at their pre-trial visit. Subjects will be asked to save each training session within the app to report to the study team upon completion of the 8-week training protocol. Subjects will be instructed to walk at a comfortable pace and to stop if they begin experiencing increased pain or discomfort.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Treatment Cohort
Description: Subjects will walk on a specified University of Florida Natural Area Teaching Laboratory's (NATL) nature trail for approximately 30 minutes, three times per week for 8 weeks while wearing the minimalist shoes provided by the study team. Time, distance, and GPS walking route will be recorded utilizing the MapMyRun smartphone application, which is free to download and easy to use. The study team will assist each subject with downloading the application onto their smartphone and provide a brief training on app use at their pre-trial visit. Subjects will be asked to save each training session within the app to report to the study team upon completion of the 8-week training protocol. Subjects will be instructed to walk at a comfortable pace and to stop if they begin experiencing increased pain or discomfort.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control Cohort
Description: Subjects will walk on hardscapes (e.g. sidewalk, asphalt, track, etc) for approximately 30 minutes, three times per week for 8 weeks while wearing the minimalist shoes provided by the study team. Similarly to the treatment group, subjects will be asked to utilize the MapMyRun smartphone application to record their training sessions. Subjects will be instructed to walk at a comfortable pace and to stop if they begin experiencing increased pain or discomfort.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Cohort
Description: Subjects will walk on hardscapes (e.g. sidewalk, asphalt, track, etc) for approximately 30 minutes, three times per week for 8 weeks while wearing the minimalist shoes provided by the study team. Similarly to the treatment group, subjects will be asked to utilize the MapMyRun smartphone application to record their training sessions. Subjects will be instructed to walk at a comfortable pace and to stop if they begin experiencing increased pain or discomfort.
Study: NCT06565520

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: transcranial direct current stimulator
Description: The total amount of participation time per qualified subject will be approximately 150 minutes over two sessions. The participant screening session will take approximately 30 minutes, which is an appropriate amount of time to complete all screening tasks. The tDCS and sham sessions will take approximately a total of 120 minutes over two sessions.~The first session will include a screening (30 minutes) to ensure they qualify for the study, followed by a treatment session (60 minutes): including non-invasive brain stimulation combined with hip strengthening exercises and functional movement testing at UNLV Maryland Campus. Subjects will return for a second treatment session (60 minutes) 2 weeks after the first.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcranial direct current stimulator
Description: The total amount of participation time per qualified subject will be approximately 150 minutes over two sessions. The participant screening session will take approximately 30 minutes, which is an appropriate amount of time to complete all screening tasks. The tDCS and sham sessions will take approximately a total of 120 minutes over two sessions.~The first session will include a screening (30 minutes) to ensure they qualify for the study, followed by a treatment session (60 minutes): including non-invasive brain stimulation combined with hip strengthening exercises and functional movement testing at UNLV Maryland Campus. Subjects will return for a second treatment session (60 minutes) 2 weeks after the first.
Study: NCT05417841

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin Degludec and Insulin Aspart Injection
Description: To evaluate the efficacy and safety of the IDegAsp BID in T2DM

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin Degludec and Insulin Aspart Injection
Description: To evaluate the efficacy and safety of the IDegAsp BID in T2DM

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin Aspart Injection
Description: To evaluate the efficacy and safety of the IDegAsp QD plus IAsp BID in T2DM
Study: NCT06575634

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Supervised exercise training
Description: Participants perform Intradialytic cycling exercise training in the hospital for 6 months (24 weeks) and 3 months (12 weeks) at home. Exercise prescription: 50-60% maximal workload for 20-30 minutes, including low intensity warm-up and cool down (30% of maximal workload).
Study: NCT06565975

Intervention type: DRUG
Intervention: Oral azacitidine
Description: As per product label, prescribed by treating physician
Study: NCT05917314

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Slimbiotic Probiotic
Description: SlimBiotics Probiotic formula contains three probiotic strains of L. fermentum:~* Limosilactobacillus fermentum K7-Lb1~* Limosilactobacillus fermentum K8-Lb1~* Limosilactobacillus fermentum K11-Lb3 The product also contains Microcrystalline cellulose.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo capsule contains microcrystalline cellulose.
Study: NCT04981782

Intervention type: OTHER
Intervention: No study specific intervention, regular care.
Description: Chiropractic care (regular care)

Intervention type: OTHER
Intervention: No study specific intervention, regular care.
Description: Chiropractic care (regular care)
Study: NCT06563492

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: insole
Description: evaluation of individuals using different insoles

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: insole
Description: evaluation of individuals using different insoles
Study: NCT06562075

Intervention type: DEVICE
Group type: OTHER
Intervention: Decoria Intense Strong
Description: Decoria® Intense Strong is a HA-based, BDDE-crosslinked dermal filler. Decoria® Intense Strong dermal fillers are injected into dermal tissue to improve and define contouring of jawline profile, supporting overlying tissue to shape facial contours to desired level of correction.~Appropriate injection volume for the jawline will be determined by the Treating investigator according to IFU
Study: NCT06260007

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tribulus terrestris
Description: Tribulus terrestris

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tribulus terrestris
Description: Tribulus terrestris

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tribulus terrestris
Description: Tribulus terrestris

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT06312761

Intervention type: DRUG
Group type: OTHER
Intervention: Relugolix 120Mg Tab
Description: Relugolix 120 mg single dose - All subjects

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Curcumin
Description: Curcumin 630 mg single dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Testosterone Undecanoate 237 MG Oral Capsule
Description: Testosterone Undecanoate 237 MG Oral Capsule

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Testosterone Undecanoate 237 MG Oral Capsule
Description: Testosterone Undecanoate 237 MG Oral Capsule
Study: NCT05227079

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MultCROC multibite forcep
Description: Alligator style 2.4 mm diameter jaws that can hold up to six samples in one pass through endoscope.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional double bite forcep
Description: Use of conventional double bite forceps that can store up to two specimens in one pass through endoscope
Study: NCT04948944

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcranial direct current stimulation
Description: the tDCS stimulator delivers very low (2mAmp) current with surface electrodes to the skull

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: transcranial direct current stimulation
Description: the tDCS stimulator delivers very low (2mAmp) current with surface electrodes to the skull
Study: NCT05901129

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Serratus posterior superior intercostal plane block (SPSIPB)
Description: Serratus posterior superior intercostal plane block is the intervention used in this study. It was performed when the patient is in lateral decubitis position. A high frequency (7-12 MHz) linear transducer of the ultrasound device is placed at the spinae scapula level in the transverse plane, and the upper medial border of the scapula, the trapezius muscle, rhomboid muscle, serratus posterior superior muscle (SPSM) and the second and third ribs are visualized. The sonovisible needle is then advanced immediately medial to the scapula, aiming for the area between the second and third ribs in order to reach the fascial plane between the SPSM and intercostal muscles. After contact of the needle with the rib gently, 1-2mL of saline is used to confirm the correct plane, and a total of 30 mL of 0.25% bupivacaine is administered to the superficial to the intercostal muscle.
Study: NCT06271109

Intervention type: PROCEDURE
Intervention: Anatomical laparoscopic liver resection for liver neoplasms
Description: resection of liver tumors laparoscopically based on surgical anatomical segmentation of the liver

Intervention type: PROCEDURE
Intervention: Non-Anatomical laparoscopic liver resection for liver neoplasms
Description: resection of liver tumors laparoscopically not based on surgical anatomical segmentation of the liver
Study: NCT06283537

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Effect of training method
Description: The effect of the training method given to midwifery students on their episiotomy application skills, satisfaction with the teaching method and self-confidence.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Effect of training method
Description: The effect of the training method given to midwifery students on their episiotomy application skills, satisfaction with the teaching method and self-confidence.
Study: NCT04053621

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Thiamine pyrophosphate
Description: 12 weeks of weekly dose of 1 gram of thiamine pyrophosphate administered in an intravenous manner with saline solution

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 12 weeks of weekly dose of 275 ml of saline solution administered in an intravenous manner

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin
Description: All participants will continue taking metformin in their previous established tolerated dose for the duration of the study

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Metformin
Description: All participants will continue taking metformin in their previous established tolerated dose for the duration of the study
Study: NCT04911517

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: long course radiotherapy + capecitabine + PD-1 monoclonal antibody treatment combinations
Description: long course radiotherapy + capecitabine + PD-1 monoclonal antibody treatment combinations in patients with locally advanced rectal cancer
Study: NCT01596088

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexrazoxane
Study: NCT05968924

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Podimetrics SmartMat
Description: Participants receive training for stepping on SmartMat each day for 6 months. Monthly phone calls will be conducted to assess foot health and mat.
Study: NCT06565065

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Osteopathic Manipulative Treatment (OMT)
Description: A full standardized lymphatic protocol will be performed, including thoracic inlet left and right, thoracoabdominal release, pelvic diaphragm release, pedal pump, splenic pump, and abdominal lymphatic pump. This treatment will be done by systematically working down and back up. The protocol will last a total of 12 minutes for each participant
Study: NCT05587010

Intervention type: DEVICE
Intervention: AFO
Description: ankle foot orthosis

Intervention type: DEVICE
Intervention: lycra sock
Description: custom fitted lycra sock

Intervention type: DEVICE
Intervention: OrthPed splint
Description: novel compression splint
Study: NCT06565065

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Osteopathic Manipulative Treatment (OMT)
Description: A full standardized lymphatic protocol will be performed, including thoracic inlet left and right, thoracoabdominal release, pelvic diaphragm release, pedal pump, splenic pump, and abdominal lymphatic pump. This treatment will be done by systematically working down and back up. The protocol will last a total of 12 minutes for each participant

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Osteopathic Manipulative Treatment (OMT)
Description: A full standardized lymphatic protocol will be performed, including thoracic inlet left and right, thoracoabdominal release, pelvic diaphragm release, pedal pump, splenic pump, and abdominal lymphatic pump. This treatment will be done by systematically working down and back up. The protocol will last a total of 12 minutes for each participant
Study: NCT06428201

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Control Group
Description: The control group receives standard care, which includes routine medical management and general physical rehabilitation exercises. This involves regular consultations with healthcare providers and exercises aimed at maintaining mobility and physical function. The control group also follows a schedule of three 45-minute sessions per week for 12 weeks, ensuring a consistent comparison with the experimental group.
Study: NCT06565065

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sham Light Touch
Description: A full standardized 12-minute session in which treaters will mimic various osteopathic manipulative techniques at specific anatomical locations without applying pressure or manipulation.
Study: NCT06428201

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Experimental Group
Description: The experimental intervention involves tele-rehabilitation-based task-specific training to enhance cognitive functions in multiple sclerosis (MS) patients. This program includes cognitive exercises targeting memory, attention, executive function, and processing speed, conducted remotely via a tele-rehabilitation platform. Patients participate in three 45-minute sessions per week for 12 weeks. Each session is guided by a trained therapist, ensuring personalized support and real-time feedback.
Study: NCT06565065

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sham Light Touch
Description: A full standardized 12-minute session in which treaters will mimic various osteopathic manipulative techniques at specific anatomical locations without applying pressure or manipulation.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sham Light Touch
Description: A full standardized 12-minute session in which treaters will mimic various osteopathic manipulative techniques at specific anatomical locations without applying pressure or manipulation.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise Protocol
Description: A full standardized moderate-intensity physical activity as defined by the Centers for Disease Control (CDC). Target heart rate for moderate-intensity exercise should be between 64 and 76% of maximum heart rate. To estimate age-related heart rate, subjects' age will be subtracted from 220. Then, that number will be multiplied by 75%, which will be standardized across all subjects in the study. Heart rate will be monitored with the use of an attached pulse-ox monitor. Treadmill speed will be adjusted accordingly so that each subject maintains a heart rate of 75% of their maximum heart rate. A brisk walk will be done on a flat treadmill and no incline will be utilized. Subjects will be allowed a minute of warm-up to get to the appropriate pace/target heart rate.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise Protocol
Description: A full standardized moderate-intensity physical activity as defined by the Centers for Disease Control (CDC). Target heart rate for moderate-intensity exercise should be between 64 and 76% of maximum heart rate. To estimate age-related heart rate, subjects' age will be subtracted from 220. Then, that number will be multiplied by 75%, which will be standardized across all subjects in the study. Heart rate will be monitored with the use of an attached pulse-ox monitor. Treadmill speed will be adjusted accordingly so that each subject maintains a heart rate of 75% of their maximum heart rate. A brisk walk will be done on a flat treadmill and no incline will be utilized. Subjects will be allowed a minute of warm-up to get to the appropriate pace/target heart rate.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise Protocol
Description: A full standardized moderate-intensity physical activity as defined by the Centers for Disease Control (CDC). Target heart rate for moderate-intensity exercise should be between 64 and 76% of maximum heart rate. To estimate age-related heart rate, subjects' age will be subtracted from 220. Then, that number will be multiplied by 75%, which will be standardized across all subjects in the study. Heart rate will be monitored with the use of an attached pulse-ox monitor. Treadmill speed will be adjusted accordingly so that each subject maintains a heart rate of 75% of their maximum heart rate. A brisk walk will be done on a flat treadmill and no incline will be utilized. Subjects will be allowed a minute of warm-up to get to the appropriate pace/target heart rate.
Study: NCT06565754

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: BFR
Description: Blood flow restriction training is an accessory to a variety of different exercise modes (e.g., resistance exercise, walking, cycling) has recently become a popular research topic. It involves the application of pressurized cuffs to the proximal portion of each lower extremity or upper extremity. It enhance blood pooling in the capillary beds of the limb muscles distal to the tourniquet or cuff.~The 3rd Generation SmartCuffs® pump (SmartCuffs® 3.0 PRO) is Personalized Pressure feature which allows for a fast, hassle-free personalized pressure calculation. With the built-in pressure sensor and on-board computer, it is calculate arterial occlusion pressure and set the optimal pressure for patient's body. There is no need for an external doppler probe or hand pump. This unit will do everything for patient. Smart Cuffs 3rd generation is FDA Approved Listed Class 1 device.~The automatized tourniquet (Smart Tools) contains a ring-shaped single- chamber

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: strengthening exercise
Description: Quadriceps strengthening exercises are part of the treatment of PFPS, but the heavy resistance exercises may aggravate knee pain. Blood flow restriction training (BFRT) provides a low-load quadriceps strengthening method to treat PFPS (Giles et al., 2017).

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: strengthening exercise
Description: Quadriceps strengthening exercises are part of the treatment of PFPS, but the heavy resistance exercises may aggravate knee pain. Blood flow restriction training (BFRT) provides a low-load quadriceps strengthening method to treat PFPS (Giles et al., 2017).
Study: NCT06569017

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 1) Artificial intelligence supported working group
Description: Pregnant women will be a personal information form, breastfeeding diagnosis and evaluation scale, postnatal breastfeeding self-efficacy scale, Lowa infant nutrition attitude scale and Edinburgh postpartum depression scale. Pregnant women in the artificial intelligence-supported study group were aged 32-37. Starting from the first week of pregnancy, a mobile breastfeeding consultancy application supported by IOS and Android will be installed on smart phones. Pregnant women will be expected to use this application actively until birth and submit their questions about breastfeeding to this artificial intelligence-supported mobile application and receive instant answers. After these applications, the breastfeeding diagnosis and evaluation scale, postnatal breastfeeding self-efficacy scale, Lowa baby nutrition attitude scale and Edinburgh postpartum depression scale will be applied again to pregnant women on the first postpartum day, sixth day, third week and third month.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Online breastfeeding counseling group led by a nurse
Description: The forms that will be applied to pregnant women in all three groups at the first meeting will also be applied to this group. 32-37 in the nurse-led online breastfeeding counseling group. Primiparous pregnant women at the gestational age will be offered 1.5 hours of breastfeeding counseling by one of the researchers, between the 32nd and 37th weeks of pregnancy, with the participation of small groups of five pregnant women in each interactive session. Pregnant women in this group will receive only one session of breastfeeding training. These trainings, which will be given by the nurse, will be carried out online via video call via WhatsApp application. After these applications, the breastfeeding diagnosis and evaluation scale, postnatal breastfeeding self-efficacy scale, Lowa baby nutrition attitude scale and Edinburgh postpartum depression scale will be applied again to pregnant women on the first postpartum day, sixth day, third week and third month.
Study: NCT05243134

Intervention type: OTHER
Intervention: Collect the clinical data
Description: We analyze the influence of the anatomic deformity on the clinical efficacy at the follow-up.

Intervention type: OTHER
Intervention: Collect the clinical data
Description: We analyze the influence of the anatomic deformity on the clinical efficacy at the follow-up.
Study: NCT05051384

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Doppler technology
Description: The study of tumor vascularization can help in the differential diagnosis and follow-up of tumors, and therefore can impact the management of patients with tumors
Study: NCT06646003

Intervention type: OTHER
Intervention: Evaluation of 6-minute walking distance and related factors in patients with chronic stroke
Description: Evaluation of 6-minute walking distance and related factors in patients with chronic stroke.